Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amy L Carr"'
Autor:
Victoria Marinucci, Patricia R. Louzon, Amy L. Carr, Jillian Hayes, Arnaldo Lopez-Ruiz, Jason Sniffen
Publikováno v:
Annals of Pharmacotherapy. 57:560-569
Background: Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) can be detected using nasal swab polymerase chain reaction (PCR) assay and is associated with clinical MRSA infection. The MRSA nasal PCR has a rapid turnaround ti
Autor:
Brandon Del Carpio, Michelle Dillon, Dahlia Hurtado, Taylor VanDenberg, Jillian E Hayes, Amy L Carr, Sarah B Minor
Publikováno v:
Open Forum Infectious Diseases. 9
Background In December 2020, ceftolozane/tazobactam (CT) was voluntarily recalled due to failed sterility tests. With this recall, clinicians were forced to utilize alternatives for multi-drug resistant (MDR) Pseudomonas (PSA) infections until CT ret
Autor:
Jillian E Hayes, Amy L Carr
Publikováno v:
Open Forum Infectious Diseases. 9
Background Timely conversion of antimicrobials from intravenous (IV) to oral (PO) route has been shown to decrease costs and length of stay (LOS) without compromising safety and efficacy of therapy. Use of oral antimicrobials may additionally prevent
Publikováno v:
Open Forum Infectious Diseases. 9
Background Candida spp. are the fourth most common cause of bloodstream infections (BSI) in the United States and have an associated mortality rate of 19-40.5%. Mortality rates are further impacted by delay in time to adequate antifungal therapy, his
Publikováno v:
Open Forum Infectious Diseases. 9
Background Gram-negative (GN) bacterial resistance is an urgent global health problem. Cefiderocol (CFDC) is active against many resistant GN pathogens, including Pseudomonas aeruginosa (PA). PROVE is an ongoing international, retrospective study ass
Autor:
Jillian Hayes, Ahmed Ghonim, Leslie Wooten, Jenny Sippel-Tompkins, Victor Herrera, Amy L Carr
Publikováno v:
Open Forum Infectious Diseases. 9
Background The use of remdesivir (RDV) in patients hospitalized with COVID-19 has resulted in a significantly shorter time to recovery, especially in patients receiving low flow oxygen. Despite the shortened time to recovery, concerns have been raise
Publikováno v:
Open Forum Infectious Diseases. 9
Background PROVE is an ongoing international, retrospective study assessing cefiderocol (CFDC) for Gram-negative (GN) infections. Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are difficult-to-treat with limited treatment options. CF
Autor:
Kathy J. Austin, Evee L. George, Thomas R. Hansen, Carol E. Hearne, Amy L. Carr, E. Lee Belden, James K. Pru
Publikováno v:
Endocrinology. 145:967-975
The interferon-stimulated gene ISG15, a ubiquitin homolog, becomes conjugated to and regulates uterine proteins in response to conceptus-derived interferon-τ on d 18 of pregnancy. It was hypothesized here that cellular localization of ISG15 within e